Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Kramer

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
Kidney360|April 4, 2022
Lower Urinary Tract Symptoms Should Be Queried When Initiating Sodium Glucose Co-Transporter 2 InhibitorsNicolas Krepostman, Holly Kramer
Advances in Chronic Kidney Disease|June 11, 2022
Realizing the Goals of the Advancing American Kidney Health Initiative: Toward a Better Future for Kidney Disease Research FundingRyan Murray, Holly Kramer
Current Opinion in Nephrology and Hypertension|April 11, 2007
Obesity and kidney disease: a big dilemmaHolly Kramer, Amy Luke
Advances in Kidney Disease and Health|November 21, 2023
Renal Diet Metamorphosis Guest Editorial for Advances in Kidney Disease and HealthHolly Kramer, Shivam Joshi
Kidney Medicine|August 25, 2020
Racial and Ethnic Disparities, Kidney Disease, and COVID-19: A Call to ActionKevin Longino, Holly Kramer
Clinical Journal of the American Society of Nephrology : CJASN|October 29, 2011
Fluid intake for kidney disease prevention: an urban myth?Alex Chang, Holly Kramer
Nephron. Clinical Practice|August 4, 2011
Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk predictionAlex Chang, Holly Kramer
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 2012
CKD progression: a risky businessAlex Chang, Holly Kramer
Seminars in Nephrology|February 5, 2013
Obesity and kidney disease: potential mechanismsChristopher Wickman, Holly Kramer
JAMA Internal Medicine|August 14, 2013
Moving dietary management of diabetes forwardHolly Kramer, Alex Chang
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
Kidney360|April 4, 2022
Lower Urinary Tract Symptoms Should Be Queried When Initiating Sodium Glucose Co-Transporter 2 InhibitorsNicolas Krepostman, Holly Kramer
Advances in Chronic Kidney Disease|June 11, 2022
Realizing the Goals of the Advancing American Kidney Health Initiative: Toward a Better Future for Kidney Disease Research FundingRyan Murray, Holly Kramer
Current Opinion in Nephrology and Hypertension|April 11, 2007
Obesity and kidney disease: a big dilemmaHolly Kramer, Amy Luke
Advances in Kidney Disease and Health|November 21, 2023
Renal Diet Metamorphosis Guest Editorial for Advances in Kidney Disease and HealthHolly Kramer, Shivam Joshi
Kidney Medicine|August 25, 2020
Racial and Ethnic Disparities, Kidney Disease, and COVID-19: A Call to ActionKevin Longino, Holly Kramer
Clinical Journal of the American Society of Nephrology : CJASN|October 29, 2011
Fluid intake for kidney disease prevention: an urban myth?Alex Chang, Holly Kramer
Nephron. Clinical Practice|August 4, 2011
Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk predictionAlex Chang, Holly Kramer
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 2012
CKD progression: a risky businessAlex Chang, Holly Kramer
Seminars in Nephrology|February 5, 2013
Obesity and kidney disease: potential mechanismsChristopher Wickman, Holly Kramer
JAMA Internal Medicine|August 14, 2013
Moving dietary management of diabetes forwardHolly Kramer, Alex Chang
Pageof 19